Related Experiment Video
Updated: Jul 4, 2026
05:36
Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
Intravenous iron in oncology
Michael Auerbach1, Harold Ballard
1Georgetown University, Washington, DC, USA. mauerbachmd@aol.com
Summary
Intravenous iron (IV Fe) can safely improve hemoglobin in patients with chemotherapy-induced anemia (CIA). Despite proven benefits, IV Fe is underused due to misunderstandings about its safety profile.
Area of Science:
- Oncology
- Hematology
Background:
- Intravenous iron (IV Fe) alongside erythropoiesis-stimulating agents (ESAs) is standard for dialysis-associated anemia, improving hemoglobin and reducing transfusions.
- Similar benefits are observed in chemotherapy-induced anemia (CIA), yet IV Fe is underutilized in this patient group.
Purpose of the Study:
- To advocate for the routine incorporation of IV Fe in treating CIA.
- To address and correct misinterpretations regarding the safety of IV Fe in oncology patients.
Main Methods:
- Review of published clinical trial experience with IV Fe in over 1000 patients.
- Analysis of adverse event data, focusing on the distinction between different IV Fe formulations.
Main Results:
- IV Fe demonstrates significant benefits in hemoglobin and hematopoietic responses for CIA patients.
- Minimal toxicity is reported when high molecular weight iron dextran is avoided.
- Cost savings and reduced ESA exposure are additional advantages.
Conclusions:
- Routine use of IV Fe is recommended for chemotherapy-induced anemia.
- Addressing safety concerns through accurate understanding of adverse events is crucial for improved patient care.
Related Concept Videos
01:25Hemodialysis III: Nursing Management
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
01:28IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...